Metastatic Colorectal Cancers Completed Phase Trials for Regorafenib (DB08896)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01996969Identification of Predictive Biomarker of Regorafenib in Refractory Colorectal CancerScreening
NCT02310477Regorafenib in Metastatic Colorectal Cancer : a Cohort Study in the Real-life Setting